11 June 2024
11 June 2024
These systems are designed for health improvement and type 2 diabetes management.
NetDose PRO is the only NVLAP-accredited digital dosimeter.
The collaboration aims to extend SHL Medical's connected device technologies through the integration of Aptar’s SaMD platform.
Roche will use ALZpath's pTau217 antibody for the development of a blood test to diagnose Alzheimer's disease.
The capital will support regulatory and clinical activities to validate the Voro Urologic Scaffold’s safety and efficacy.
Sano Genetics will offer over 200 cost-free tests to individuals with a family history or a diagnosis of motor neurone disease (MND).
The UK company is currently advancing its adaptive neuromodulation system through clinical trials.
The South Korean company announced that its multicenter, single-arm trial will examine 15 patients at hospitals across the US with resistant hypertension.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
